Earli nets $40m Series A

Earli, an early cancer detection platform, has raised $40 million in Series A funding.

12 January 2021•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Technology Briefs